Skip to content

Randomized controlled clinical study on treatment of mild and moderate stress urinary incontinence in women with lattice CO2 laser

Randomized controlled clinical study on treatment of mild and moderate stress urinary incontinence in women with lattice CO2 laser

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077962
Enrollment
Unknown
Registered
2023-11-24
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress urinary incontinence

Interventions

Experimental group:Dot array CO2 laser treatment+pelvic floor biofeedback electrical stimulation treatment

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: ? No contraindication of pelvic floor electrical stimulation and laser treatment; ? Meets SUI mild to moderate diagnostic criteria; ? Patients with sexual life, age = 50 years old (if postpartum, those who have menstruation); ? Those who have not undergone vaginal sling or patch surgery; ? Informed consent and signed the treatment consent. Grading standard: Ingelman-Sundberg grading method is used for clinical symptoms: ? Mild: Urinary incontinence occurs when coughing and sneezing, and urine pad is not required; ? Moderate: urinary incontinence occurs in daily activities such as running and jumping, fast walking, etc., and requires the use of urine pads; ? Severe: Urinary incontinence occurs when slight movement and prone position change.

Exclusion criteria

Exclusion criteria: ? Meet the SUI severe diagnostic criteria; ? Urgent urinary incontinence, mixed urinary incontinence and other types of urinary incontinence; ? History of surgical treatment or pelvic floor surgery for urinary incontinence; ? Acute genitourinary tract infection; ? Severe heart, brain, liver, kidney and nervous system diseases; ? Intraepithelial neoplasia and malignant tumor of cervix, vagina and vulva; ? Uterine prolapse degree III and above; ? Abnormal uterine bleeding. Any one of the above items is not included in this study.

Design outcomes

Primary

MeasureTime frame
International Commission on Urinary Incontinence Questionnaire;

Secondary

MeasureTime frame
Urinary incontinence quality of life questionnaire;3D color ultrasound of pelvic floor;

Countries

China

Contacts

Public ContactBolong Liu

The Third Affiliated Hospital of Sun Yat-sen University

liublong@mail.sysu.edu.cn+86 135 6037 8174

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026